Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10729654 Dry powder composition comprising long-chain RNA

Patent 10729654 was granted and assigned to CureVac on August, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

CureVac

Current Assignee

CureVac

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107296540

Date of Patent

August 4, 2020

Patent Application Number

155753010

Date Filed

May 20, 2016

Patent Citations Received

‌

US Patent 12109275 Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein

‌

US Patent 11491112 Lyophilization of RNA

‌

US Patent 11534405 Dry powder composition comprising long-chain RNA

‌

US Patent 11965000 Respiratory syncytial virus (RSV) vaccine

‌

US Patent 12083190 Rabies vaccine

‌

US Patent 11458100 Lyophilization of RNA

‌

US Patent 11273125 Preparation of desiccated liposomes for use in compressible delivery systems

‌

US Patent 11661634 Method for producing RNA

...

Patent Primary Examiner

‌

Kimberly Chong

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10729654 Dry powder composition comprising long-chain RNA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API